NYSE$EPC
Edgewell Personal Care · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Delivered strong organic net sales and earnings per share growth, expanded gross margin and generated substantial cash.
Edgewell Personal Care announced strong Q3 2023 results, with net sales increasing by 4.2% to $650.0 million and organic net sales increasing by 4.5%. GAAP EPS grew by 77% and Adjusted EPS grew by 14%. The company is on track to deliver organic net sales growth slightly above the mid-point, adjusted EPS at the high-end, and adjusted EBITDA slightly above the high-end of the previously provided ranges.
- Net sales were $650.0 million, an increase of 4.2% compared to the prior year quarter, or 4.5% on an organic basis.
- GAAP Diluted EPS was $1.01 for the third fiscal quarter compared to $0.57 in the prior year quarter.
- Adjusted EPS was $0.98, inclusive of a $0.09 unfavorable impact from currency movements, compared to $0.86 in the prior year quarter.
- Ended the third fiscal quarter with $207.4 million in cash on hand.
Headline financials
Revenue & EPS history
Edgewell · Revenue · Quarterly
$650M
Revenue by segment
Edgewell · $569M total across 2 segments · Q3 2023
- Wet Shave$324M-0.7%57.0%
- Sun and Skin Care$245M+13.3%43.0%
Forward guidance
The Company is providing the following updated outlook assumptions for fiscal 2023:
Tailwinds
- Reported net sales are expected to increase slightly above the mid-point of the the range of 2% to 4%.
- Organic net sales are now expected to increase slightly above the mid-point of the range of 3% to 5%
- GAAP EPS is now expected to be in the range of $1.95 to $2.15
- Adjusted EPS is now expected to be at the high end of the range of $2.30 to $2.50
- Adjusted EBITDA is now expected to be slightly above the high end of the range of $320 to $335 million
Headwinds
- Includes an estimated 60-basis point inorganic benefit in net sales from the acquisition of Billie, net of prior year Edgewell sales to Billie and an estimated 120-basis point (previously 115-basis point) negative impact from currency movements
- Includes: Restructuring charges*, acquisition and integration costs, Sun Care reformulation costs, Canadian Pension wind-up costs, and favorable resolution of legal matters
- Includes an estimated $0.38 EPS (previously $0.43) unfavorable impact from foreign currency movements
- Gross margin is now expected to be flat to the prior year (previously 30-basis point increase)
- Includes an estimated $26 million (previously $29 million) unfavorable impact from foreign currency changes
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
+0.2%
Avg return
Earnings day
+0.1%
Avg return
5 days after
-0.8%
Avg return
30 days after
56%
38 / 68 earnings
Positive
+20.1%
Q1 2020
Best reaction
-17.0%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | +2.2% | -13.9% | -13.1% | |
| Q1 2026 | -4.6% | +5.5% | -4.0% | |
| Q4 2025 | -2.7% | -10.8% | -8.0% | |
| Q2 2025 | -10.2% | -4.3% | -9.9% | |
| Q1 2025 | -9.5% | -5.8% | -2.5% | |
| Q4 2024 | -0.5% | -2.8% | +1.1% | |
| Q3 2024 | -0.2% | -0.7% | +5.8% | |
| Q2 2024 | +4.4% | +7.9% | +3.4% | |
| Q1 2024 | +5.6% | +6.6% | +2.8% | |
| Q4 2023 | -2.5% | +1.6% | -0.7% | |
| Q3 2023 | -2.8% | -2.1% | -2.1% | |
| Q2 2023 | +1.9% | +2.6% | -2.0% | |
| Q1 2023 | +4.7% | +5.7% | -3.8% | |
| Q4 2022 | +0.9% | +2.8% | +3.5% | |
| Q3 2022 | +2.6% | +4.0% | -3.9% | |
| Q2 2022 | -11.8% | -10.6% | -8.8% | |
| Q1 2022 | -11.0% | -15.1% | -17.0% | |
| Q4 2021 | +13.9% | +14.6% | +17.2% | |
| Q3 2021 | +8.0% | +8.8% | +0.6% | |
| Q2 2021 | +9.1% | +10.4% | +13.2% | |
| Q1 2021 | +0.6% | -2.7% | +1.5% | |
| Q4 2020 | +9.2% | +13.2% | +12.1% | |
| Q3 2020 | -7.8% | -5.0% | -1.0% | |
| Q2 2020 | +11.1% | +2.7% | +22.6% | |
| Q1 2020 | +20.1% | +10.4% | -2.1% | |
| Q4 2019 | -11.4% | -15.5% | -13.2% | |
| Q3 2019 | +7.5% | +2.2% | +2.8% | |
| Q2 2019 | -17.0% | -15.1% | -22.8% | |
| Q1 2019 | +6.6% | +10.0% | +9.1% | |
| Q4 2018 | -9.6% | -6.1% | -11.6% | |
| Q3 2018 | +2.8% | +2.4% | -1.3% | |
| Q2 2018 | -1.4% | +2.2% | +5.1% | |
| Q1 2018 | -4.5% | -4.4% | +0.8% | |
| Q4 2017 | -6.5% | -5.1% | -2.8% | |
| Q3 2017 | +2.5% | +3.3% | +2.2% | |
| Q2 2017 | +5.4% | +3.6% | +3.5% | |
| Q1 2017 | -1.4% | -1.7% | -2.4% | |
| Q4 2016 | +8.2% | +8.7% | +1.7% | |
| Q3 2016 | -5.4% | -2.9% | -5.9% | |
| Q2 2016 | -3.7% | — | — | |
| Q1 2016 | -0.2% | — | — | |
| Q4 2015 | -3.0% | — | — | |
| Q3 2015 | +0.4% | — | — | |
| Q2 2015 | +0.9% | — | — | |
| Q1 2015 | -1.6% | — | — | |
| Q4 2014 | -0.0% | — | — | |
| Q3 2014 | -0.3% | — | — | |
| Q2 2014 | +3.6% | — | — | |
| Q1 2014 | -0.6% | — | — | |
| Q4 2013 | +1.4% | — | — | |
| Q3 2013 | -2.5% | — | — | |
| Q2 2013 | +3.8% | — | — | |
| Q1 2013 | +2.8% | — | — | |
| Q4 2012 | +0.0% | — | — | |
| Q3 2012 | -13.5% | — | — | |
| Q2 2012 | -2.2% | — | — | |
| Q1 2012 | +2.3% | — | — | |
| Q4 2011 | -1.7% | — | — | |
| Q3 2011 | +1.0% | — | — | |
| Q2 2011 | +0.5% | — | — | |
| Q1 2010 | +0.3% | — | — | |
| Q1 2011 | +0.1% | — | — | |
| Q2 2010 | +1.5% | — | — | |
| Q4 2008 | +1.5% | — | — | |
| Q4 2010 | +1.5% | — | — | |
| Q3 2009 | +4.3% | — | — | |
| Q3 2010 | +4.3% | — | — | |
| Q4 2009 | +4.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro